#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma Cardiac arrest Non-small cell lung cancer Head and neck cancer Pseudomyxoma peritonei Non-Hodgkin's lymphoma Glycogen storage disease type II Cholangitis sclerosing Dedifferentiated liposarcoma Prolymphocytic leukaemia Sarcoma Isodicentric chromosome 15 syndrome Exudative retinopathy Extra-osseous Ewing's sarcoma Kidney transplant rejection More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Life with Disease Osteosarcoma – Diagnostics Congenital nephrogenic diabetes insipidus Arterial tortuosity syndrome – Diagnostics MELAS syndrome – Trials in Disease Ewing’s sarcoma – Diagnostics Antisynthetase syndrome – Basic Information Piriformis syndrome – Diagnostics Primary immunodeficiency syndrome Basal cell naevus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    METAMIZOLE SODIUM Tianeptine Sodium Tapentadol Hydrochloride Troriluzole Cx-037231 Toldc Levamlodipine Succinate Tin816 Oxazepam Rmc-6291 Zibotentan FIBRIN Keto-Valine Calcium Etelcalcetide Mbf-118 Islatravir Ribonucleic Acid K10 Raltegravir Rizolipase Ulotaront More therapies…

    Learn about Your Condition

    Rhabdoid tumour of the kidney Chondrocalcinosis Burkitt's lymphoma Alopecia areata Immunodeficiency congenital Myotonia Plasma cell leukaemia Basal cell carcinoma Pneumonia bacterial Carotid arteriosclerosis Cervical dysplasia Glycogen storage disorder Marfan's syndrome Idiopathic pulmonary fibrosis Mucopolysaccharidosis II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • Study on the Effects of ILB and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Riluzole
    Norway

  • Study on the Effect of Amoxicillin in Preschool Children with Pneumonia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin Trihydrate
    Norway

  • Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Cortisone
    • Hydrocortisone
    Norway

  • Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Sodium Chloride
    • Tenecteplase
    Belgium Denmark Finland Ireland Norway Sweden

  • Study on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder

    Recruiting

    1 1 1
    Investigated Drugs:
    • Midazolam Hydrochloride
    • Ketamine
    Norway

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Enzalutamide
    • Fludrocortisone
    Austria Czechia Denmark Finland France Germany +8
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Asundexian Dexamethasone Pembrolizumab Cisplatin Hydrocortisone Prednisone Tenecteplase Nivolumab Apixaban Lidocaine Daratumumab Pegfilgrastim Baricitinib Ferric Derisomaltose Paracetamol Dexamethasone Acetate Piperacillin Sodium Cyclophosphamide Lenalidomide Carboplatin Bi 690517 Placebo Tazobactam Sodium Doxorubicin Hydrochloride Cortisone Gemcitabine Gemcitabine Hydrochloride Empagliflozin Nitrous Oxide Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!